Abstract
Crohn's disease is a chronic, inflammatory bowel disease of unknown cause. A significant development in the treatment of Crohn's disease has been the Introduction of Infliximab (Remicade),a chimeric monoclonal antibody that binds and neutralizes tumor necrosis factor alpha and also induces apoptosis in T cells. The most common side effects of Infliximab are infections and allergic reactions. Serious side effects include reactivation of tuberculosis, lymphoma and bone marrow depression. We would like to describe a severe uncommon side effect of Infliximab. A fifteen years old boy with Crohn's disease was admitted because of severe herpes zoster Crohn's disease was diagnosed at the age of 10 years with short stature, abdominal pain and diarrhea. He was treated with azathioprine, prednisone, antibiotics and growth hormone but could not achieve clinical remission. a course of three Infliximab infusions was given with marked clinical improvement. Three weeks after the last infusion he developed Herpes zoster infection which responded to intravenous acyclovir. This case report is, to our knowledge, the first report of Herpes Zoster infection as a complication of Infliximab administration.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.